Banner - NPPA Connect
NP/PA Connect
News
Media
Around the PracticeBetween The LinesCase-Based Peer PerspectiveClinical Case CollectiveDermViewExpert PerspectivesFellows Face OffFrontline ForumMedical World NewsPatient PerspectivesPodcastsReadout360Recognize and Refer
Conferences
Conference CoverageConference Listing
Events
Case-Based Roundtable
More
Publication
Dermatology Times
CME/CE
Resources
DermIQInteractive ToolsJob BoardPartner PerspectivesPerspectives in DermatologyPollsSponsored ContentSponsored ResourcesSpot Test
Editorial Advisory Board
Partners

Subscribe

  • NP/PA Connect
  • News
  • Media
  • Conferences
  • Events
  • Publication
  • CME/CE
  • Resources
  • Editorial Advisory Board
  • Partners
  • Subscribe
  • Acne
  • Actinic Keratosis
  • Aesthetics
  • Alopecia
  • Atopic Dermatitis
  • Buy-and-Bill
  • COVID-19
  • Case-Based Roundtable
  • Chronic Hand Eczema
  • Chronic Spontaneous Urticaria
  • Drug Watch
  • Eczema
  • General Dermatology
  • Hidradenitis Suppurativa
  • Melasma
  • Pediatric Dermatology
  • Pigmentary Disorders
  • Practice Management
  • Precision Medicine and Biologics
  • Prurigo Nodularis
  • Psoriasis
  • Psoriatic Arthritis
  • Rare Disease
  • Rosacea
  • Skin Cancer
    • Non-Melanoma Skin Cancers
  • Vitiligo
  • Wound Care
Advertisement

Joan Merrill, MD

Advertisement

Articles by Joan Merrill, MD

Phase 2 SLEek Clinical Trials Showed Promising Results for Patients With Systemic Lupus Erythematosus

ByLauren Buchanan, MA, Managing Editor,Joan Merrill, MD
June 13th 2023

Joan Merrill, MD, explained the study's efficacy and safety outcomes and looks forward to phase 3 trials ahead.

Advertisement

Latest Updated Articles

  • Phase 2 SLEek Clinical Trials Showed Promising Results for Patients With Systemic Lupus Erythematosus
    Phase 2 SLEek Clinical Trials Showed Promising Results for Patients With Systemic Lupus Erythematosus

    Published: June 13th 2023 | Updated:



Advertisement
Advertisement

Trending on Dermatology Times

1

AbbVie Files for Vitiligo Indication, Putting Systemic Therapy Under Regulatory Review

2

Nutrafol Expands Portfolio with First and Only Hair Loss Supplement for Male Patients 50 and Older

3

Icotrokinra Shows Superior Efficacy Over Advanced Oral Therapies in New Psoriasis Meta-Analysis

4

Introducing Dermatology Times NP/PA Connect

5

FDA Accepts Galderma’s BLA Resubmission for Liquid Neuromodulator RelabotulinumtoxinA

  • About
  • Advertise
  • Contact Us
  • Job Board
  • Do Not Sell My Information
  • Terms and Conditions
  • Privacy Policy
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

609-716-7777

Brand Logo

© 2025 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us